U Vogt

734 citations

32 papers · 580 indexed · h-index 13

Impact in

Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Bone health and treatments
- Cancer Cells and Metastasis
Cancer Research

Papers in

Oncology 15
- HER2/EGFR in Cancer Research 8
- Cancer Cells and Metastasis 3
Cancer Research 7
- Cancer Genomics and Diagnostics 4
- Breast Cancer Treatment Studies 3

Co-authors: C. M. Schlotter U. Bosse Burkhard Brandt Krzysztof Piotr Bielawski Heike Allgayer Bogdan Falkiewicz Hubert Serve Carsten Müller‐Tidow
Journals: Gene (3 papers)Journal of Clinical Oncology (3 papers)British Journal of Cancer (2 papers)Breast Cancer Research (2 papers)Molecular Diagnosis & Therapy (1 paper)
Partner nations: Germany United States Poland

In The Last Decade

U Vogt

29 papers receiving 566 citations

Peers

Countries citing papers authored by U Vogt

Since Specialization

Citations

This map shows the geographic impact of U Vogt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U Vogt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U Vogt more than expected).

Fields of papers citing papers by U Vogt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U Vogt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U Vogt. The network helps show where U Vogt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside U Vogt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with U Vogt Line = papers co-authored together U Vogt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TWIST1 Gene expression as a biomarker for predicting primary doxorubicin resistance in breast cancer SHILAP Revista de lepidopterología ·Nina Engelhardt, R M Stein, Mahmut Müslümanoğlu, (unknown), Gonzalo, Adnan Aydıner, U Vogt, Tunahan Çakır, Т. С. Черкасова, Sevilhan Artan	2019	4
2	Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival Hormone Molecular Biology and Clinical Investigation ·C. M. Schlotter, L. Tietze, U Vogt, Linh Dieu Phan, Antje Hahn	2017	15
3	Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes European Journal of Cancer ·Cornelia Liedtke, Jens Packeisen, Kenneth R. Hess, U Vogt, Ludwig Kiesel, Christian Kersting, 幸平坂田, Burkhard Brandt, Horst Buerger	2011	7
4	Molecular targeted therapies for breast cancer treatment Breast Cancer Research ·C. M. Schlotter, U Vogt, Heike Allgayer, Burkhard Brandt	2008	60
5	Whole Genome Expression Analysis for Biologic Rational Pathway Modeling Molecular Diagnosis & Therapy ·Dirk Kemming, U Vogt, Nicola Tidow, C. M. Schlotter, Horst Bürger, Mike W. Helms, Eberhard Korsching, A Granetzny, Kate Mazza, Ludger Hillejan, Alessandro Marra, Qian Ying Liu, Pingru Xiang, Burkhard Brandt	2006	8
6	Surgery in the tri-modality treatment of small cell lung cancer.Stage-dependent survival European Journal of Cardio-Thoracic Surgery ·A Granetzny, 休明前野, Staffan Sandberg, J. Biaise, U Vogt, E. Hecker, Olaf Koch, F. Klinke	2006	20
7	cDNA micro array profiling indicates selection of therapy resistant breast cancer cell clones in vivo Journal of Clinical Oncology ·U Vogt, Nicola Tidow, V.I. Selikhova, Matthew D. Christensen, Dirk Kemming, C. M. Schlotter	2005	3
8	A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer The Annals of Thoracic Surgery ·A Granetzny, VoldeDron, U. Bosse, W. Wagner, Olaf Koch, U Vogt, 徐永恒, F. Klinke	2003	6
9	C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer Breast Cancer Research ·C. M. Schlotter, U Vogt, U. Bosse, Marie-Thérèse Zenner, Rizqi Tri Rachmawati	2003	59
10	Bedeutung DNA-Bild-zytometrischer Parameter und etablierter Prognosefaktoren für krankheitsfreies Überleben (DFS) und Gesamtüberleben (OS) nodal-negativer Mammakarzinompatientinnen Zentralblatt für Gynäkologie ·C. M. Schlotter, U Vogt, W.-S.L.M. Moh, Katja Wassmann	2003	0
11	Cyclin A1 is highly expressed in aggressive testicular germ cell tumors Cancer Letters ·Carsten Müller‐Tidow, Sven Diederichs, Mark Schrader, U Vogt, Kurt Miller, Wolfgang E. Berdel, Hubert Serve	2003	36
12	p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer Journal of Cancer Research and Clinical Oncology ·U Vogt, Anna J. Żaczek, F. Klinke, A Granetzny, Krzysztof Piotr Bielawski, Bogdan Falkiewicz	2002	27
13	Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer British Journal of Cancer ·Carsten Müller‐Tidow, June Dahy, Sven Diederichs, S Shender Barry, Martin Möller, U Vogt, Ralf Metzger, Paul M. Schneider, Wolfgang E. Berdel, Hubert Serve	2001	12
14	Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer1Published in conjunction with A Wisconsin Gathering Honoring Waclaw Szybalski on the occasion of his 75th year and 20 years of Editorship-in-Chief of Gene, 10–11 August, 1997, University of Wisconsin, Madison, WI, USA.1 Gene ·U Vogt, Krzysztof Piotr Bielawski, C. M. Schlotter, U. Bosse, Bogdan Falkiewicz, Anna J. Podhajska	1998	39
15	p53 protein expression in colorectal adenomas: an immunohistochemical study using an antigen retrieval system Histopathology ·Eva Karamitopoulou, Elias Perentes, Ioannis Diamantis, U Vogt, W Wegmann	1995	11
16	Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content Gene ·Burkhard Brandt, U Vogt, Frederike L. Harms, U. Bosse, K. S. Zänker, Gerd Assmann	1995	26
17	Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: Double-differential polymerase chain reaction (ddPCR) for clinical diagnosis Gene ·Burkhard Brandt, U Vogt, C. M. Schlotter, Christian Jackisch, R. Werkmeister, Michaël Thomas, M. von Eiff, U. Bosse, Gerd Assmann, Kurt S. Zänker	1995	32
18	The traumatic aneurysm of intracranial vessels Neurosurgical Review ·M Sabbioni, U Vogt	1980	1
19	[Modern chemotherapy and maxillary osteomyelitis in infants and children]. PubMed ·U Vogt	1956	1
20	[The role of postural nystagmus in the evaluation of post-traumatic brain injuries]. PubMed ·U Vogt	1954	1

About U Vogt

U Vogt is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Neurology, having authored 32 papers that have together received 580 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Lung Cancer Treatments and Mutations (6 papers), Molecular Biology Techniques and Applications (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (320 citations), Cancer Research (114 citations), Radiology, Nuclear Medicine and Imaging (110 citations), Molecular Biology (293 citations) and Immunology and Allergy (22 citations). U Vogt has collaborated with scholars based in Germany, United States and Poland. Frequent co-authors include C. M. Schlotter, U. Bosse, Burkhard Brandt, Krzysztof Piotr Bielawski, Heike Allgayer, Bogdan Falkiewicz, Hubert Serve, Carsten Müller‐Tidow, Wolfgang E. Berdel and Ralf Metzger. Their work appears in journals such as Gene, Journal of Clinical Oncology, British Journal of Cancer, Breast Cancer Research and Molecular Diagnosis & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact